UK Biotech Monument Uses Repurposed Drugs To Target CNS Conditions
Initial Programs In Cognitive Impairment In Schizophrenia, Post-Operative Cognitive Decline
• By Sten Stovall
Spinout has access to vast library of validated CNS biomarkers created by its parent • Source: Alamy 
